Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Adagio Medical Holdings (ADGM) Income from Continuing Operations (2023 - 2026)

Adagio Medical Holdings has reported Income from Continuing Operations over the past 4 years, most recently at 5871000.0 for Q1 2026.

  • Quarterly Income from Continuing Operations rose 25.64% to 5871000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 22208000.0 through Mar 2026, up 24.91% year-over-year, with the annual reading at 24319000.0 for FY2025, 61.5% up from the prior year.
  • Income from Continuing Operations was 5871000.0 for Q1 2026 at Adagio Medical Holdings, down from 4611000.0 in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at 4611000.0 in Q4 2025 and troughed at 9568000.0 in Q1 2024.
  • The 4-year median for Income from Continuing Operations is 6150000.0 (2023), against an average of 6725500.0.
  • Year-over-year, Income from Continuing Operations skyrocketed 50.92% in 2024 and then crashed 36.15% in 2025.
  • A 4-year view of Income from Continuing Operations shows it stood at 5909000.0 in 2023, then increased by 20.56% to 4694000.0 in 2024, then grew by 1.77% to 4611000.0 in 2025, then decreased by 27.33% to 5871000.0 in 2026.
  • Per Business Quant, the three most recent readings for ADGM's Income from Continuing Operations are 5871000.0 (Q1 2026), 4611000.0 (Q4 2025), and 6391000.0 (Q3 2025).